Literature DB >> 11444852

Change in expression of GBP28/adiponectin in carbon tetrachloride-administrated mouse liver.

M Yoda-Murakami1, M Taniguchi, K Takahashi, S Kawamata, K Saito, N H Choi-Miura, M Tomita.   

Abstract

GBP28 (gelatin-binding protein of 28 kDa)/adiponectin is an adipocyte-producing plasma protein proposed to interact with the extracellular matrix. To examine the production of GBP28 in non-adipose tissues, we herein analyzed its expression and localization in mouse livers before and after CCl(4) treatment. In immunohistochemical analyses, the boundary of hepatocytes provided positive signals for GBP28 after 3-6 h and their cytoplasm was intensely stained after 18 h of CCl(4) treatment. Quantitative RT-PCR and in situ hybridization revealed that GBP28 mRNA expression was markedly elevated in CCl(4)-treated mouse livers. These results suggest that the circulating GBP28 binds the extracellular matrices of hepatocytes during the initial stage of CCl(4)-induced hepatic injury and the damaged hepatocytes themselves started to produce GBP28 thereafter. The induced expression of GBP28 was also observed in human hepatoma HepG2 cells after treatment with IL-6. Thus, GBP28 is also produced by the liver, where it undergoes tissue damage-induced transcriptional regulation. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11444852     DOI: 10.1006/bbrc.2001.5134

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

1.  Vascular smooth muscle cell-derived adiponectin: a paracrine regulator of contractile phenotype.

Authors:  Min Ding; Ana Catarina Carrão; Robert J Wagner; Yi Xie; Yu Jin; Eva M Rzucidlo; Jun Yu; Wei Li; George Tellides; John Hwa; Tamar R Aprahamian; Kathleen A Martin
Journal:  J Mol Cell Cardiol       Date:  2011-09-17       Impact factor: 5.000

2.  Study of adiponectin in chronic liver disease and cholestasis.

Authors:  Tary A Salman; Naglaa Allam; Gasser I Azab; Ahmed A Shaarawy; Mona M Hassouna; Omkolsoum M El-Haddad
Journal:  Hepatol Int       Date:  2010-10-09       Impact factor: 6.047

Review 3.  Adiponectin as a Potential Therapeutic Target for Prostate Cancer.

Authors:  Hanuma Kumar Karnati; Manas Kumar Panigrahi; Yazhou Li; David Tweedie; Nigel H Greig
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

Review 4.  Adiponectin receptor signalling in the brain.

Authors:  John Thundyil; Dale Pavlovski; Christopher G Sobey; Thiruma V Arumugam
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

5.  Adiponectin, Insulin Sensitivity and Diabetic Retinopathy in Latinos With Type 2 Diabetes.

Authors:  Jane Z Kuo; Xiuqing Guo; Ronald Klein; Barbara E Klein; Pauline Genter; Kathryn Roll; Yang Hai; Mark O Goodarzi; Jerome I Rotter; Yii-Der Ida Chen; Eli Ipp
Journal:  J Clin Endocrinol Metab       Date:  2015-05-28       Impact factor: 5.958

Review 6.  Adiponectin action from head to toe.

Authors:  Karine Brochu-Gaudreau; Charlotte Rehfeldt; Richard Blouin; V Bordignon; Bruce D Murphy; Marie-France Palin
Journal:  Endocrine       Date:  2009-12-01       Impact factor: 3.633

7.  The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice.

Authors:  Aimin Xu; Yu Wang; Hussila Keshaw; Lance Yi Xu; Karen S L Lam; Garth J S Cooper
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

8.  Relationship between adiponectin and left atrium size in uncomplicated obese patients: adiponectin, a link between fat and heart.

Authors:  Juan Ybarra; Eugenia Resmini; Francesc Planas; Francesc Navarro-López; Susan Webb; Jose Maria Pou; Alicia Santos; Carlos Ballesta-López
Journal:  Obes Surg       Date:  2009-07-23       Impact factor: 4.129

9.  Serum level of adiponectin correlated with gender and genotype in patients with chronic hepatitis C.

Authors:  Qing-Hua Meng; Zhong-Hui Duan; Zun-Hui Lin; Hong-Wei Yu; Juan Li; Ya Liu
Journal:  Dig Dis Sci       Date:  2008-09-05       Impact factor: 3.199

10.  The adipose tissue production of adiponectin is increased in end-stage renal disease.

Authors:  Maria P Martinez Cantarin; Scott A Waldman; Cataldo Doria; Adam M Frank; Warren R Maley; Carlo B Ramirez; Scott W Keith; Bonita Falkner
Journal:  Kidney Int       Date:  2013-01-02       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.